SCHEMBL6175486

SCHEMBL6175486

CC(c1ccncc1C(N)=O)C1(C(C)c2ccncc2C(N)=O)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CCNA2 P20248 2/20 0.35
CDK2 P24941 2/20 0.35
CCNA1 P78396 2/20 0.35
CXCR3 P49682 2/20 0.34
ROCK2 O75116 1/20 0.34
FLT1 P17948 1/20 0.33
KDR P35968 1/20 0.33
LMNA P02545 1/20 0.33
AR P10275 1/20 0.33
AHR P35869 1/20 0.33
SYK P43405 1/20 0.33
LIPE Q05469 1/20 0.33
TRPV1 Q8NER1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172522 0.92 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172844 0.88 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174774 0.88 SLC5A1 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173899 0.88 ALDH1A1 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173429 0.85 POLB (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175872 0.85 EPHX2 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174636 0.85 ALDH1A1 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6171813 0.85 IGF1R (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6177902 0.84 CYP2C9 (0.35) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173440 0.84 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed